AUSTIN, Texas , Nov. 21, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. , (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in
Company Also Added Key Members to the Senior Management Team Barbara Ruskin J.D . Ph.D. Appointed SVP, General Counsel and Chief Patent Officer Nenad Sarapa M.D. M.S . Appointed SVP of Clinical Development Conrad Jordaan Appointed SVP of Finance and Corporate Controller AUSTIN, Texas , Nov.